Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Economic Burden of Cancer

The Economic Burden of Cancer Journal of MANAGED CARE MANAGED CARE IN ONCOLOGY Andrew Walker Economist, Department of Public Health INTRODUCTION programme. 1 There is good evidence that a screening programme for colorectal cancer will find asymptomatic Cancer is consistetly seen as one of the most important tumours, and as a result this disease will appear relatively disease groupings for national health policy, being more important. This would be the case even if we included in the Health of the Nation targets for England could achieve no health gain from the screening and Wales as well as Planning and Priorities Guidance programme at all. As health checks become increasingly for Scotland. From an-economics perspective, is this common, comparisons of incidence data will become prominence deserved? And are some primary cancer less meaningful. sites more important than others? Mortality data offers increased sophistication, but this This paper considers how disease burdens are gives no differentiation between deaths at an early age, compared, how the burden of different cancer sites can e.g. from cervical or ovarian cancer, and those at an be compared and what information policy-makers want. advanced age, e.g. prostate cancer. It thus gives no This questions the value ofmaking detailed calculations indication of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Managed Care SAGE

The Economic Burden of Cancer

Walker, Andrew
Journal of Managed Care , Volume 1 (2): 4 – Jun 1, 1997
Download PDF
4 pages

Loading next page...
 
/lp/sage/the-economic-burden-of-cancer-7UJSYjstoH

References (10)

Publisher
SAGE
Copyright
© 1997 SAGE Publications
ISSN
1363-9595
DOI
10.1177/136395959700100207
Publisher site
See Article on Publisher Site

Abstract

Journal of MANAGED CARE MANAGED CARE IN ONCOLOGY Andrew Walker Economist, Department of Public Health INTRODUCTION programme. 1 There is good evidence that a screening programme for colorectal cancer will find asymptomatic Cancer is consistetly seen as one of the most important tumours, and as a result this disease will appear relatively disease groupings for national health policy, being more important. This would be the case even if we included in the Health of the Nation targets for England could achieve no health gain from the screening and Wales as well as Planning and Priorities Guidance programme at all. As health checks become increasingly for Scotland. From an-economics perspective, is this common, comparisons of incidence data will become prominence deserved? And are some primary cancer less meaningful. sites more important than others? Mortality data offers increased sophistication, but this This paper considers how disease burdens are gives no differentiation between deaths at an early age, compared, how the burden of different cancer sites can e.g. from cervical or ovarian cancer, and those at an be compared and what information policy-makers want. advanced age, e.g. prostate cancer. It thus gives no This questions the value ofmaking detailed calculations indication of

Journal

Journal of Managed Care – SAGE

Published: Jun 1, 1997

There are no references for this article.